Cell Painting – Molecular Imaging in Drug Discovery
Griffin Ferrara2021-04-06T13:12:40-05:00Drug discovery is the process by which potential new medicines are identified, repurposed and/or designed. This involves a wide [...]
Cell-Subtype Selection in the Creation of a 3D Liver Fibrosis Model
Griffin Ferrara2021-03-19T14:18:00-05:00Highlights 3D liver fibrosis models typically incorporate both hepatocytes and various non-parenchymal (NPC) populations. Stimulation of these models [...]
Bruker and Visikol Partner to Launch Light-Sheet Imaging Services
Griffin Ferrara2021-03-09T11:15:45-05:00Hampton, NJ – March 9th, 2021 – Visikol today announced its partnership with Bruker to use Bruker’s flagship MuVi [...]
Visikol Expands Product Portfolio with New Tissue Slicers
Griffin Ferrara2021-03-05T15:42:58-05:00Visikol was originally founded as a products oriented company when it launched its Visikol® HISTO™ portfolio of reagents and [...]
Visikol named to Pharma Tech Outlook’s Top Emerging Pharma Outsourcing Companies of 2021
Griffin Ferrara2021-03-05T15:57:32-05:00Pharma Tech Outlook acknowledges Visikol and how the company is leveraging its advanced imaging and 3D cell culture solutions [...]
Using Noise Reduction Methods in ImageJ to Produce High Quality Data
Griffin Ferrara2021-02-25T14:34:56-05:00After completing the imaging process for your desired biological model, you may find that some of your images have [...]
Leica Biosystems and Visikol to Host Multiplex Webinar
Griffin Ferrara2021-04-06T13:10:13-05:00Visikol CEO Dr. Michael Johnson will be hosting a webinar with Leica Biosystems discussing multiplex imaging and the Leica [...]
Our Multiplex Immunolabeling Approach
Griffin Ferrara2021-02-03T15:56:14-05:00Immunohistochemistry is routinely used to localize and study the distribution of proteins in tissues. Most staining methods are limited [...]
Visikol Launches BitSlide, Cloud-Based Digital Pathology Slide Visualization Platform
Griffin Ferrara2021-02-09T14:40:29-05:00Visikol has been a leader in advanced bioimaging through its portfolio of cutting-edge technologies and innovative drug discovery, bioimaging, [...]
Using Immunohistochemistry and Multiplex Slide Labeling for Tumor Research
Griffin Ferrara2021-03-02T12:59:25-05:00Accurate prediction and prognosis as well as patient stratification for precision therapy are the most important and difficult issues [...]